IMC Chicago’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
IMC Chicago's SMMT Position: Q3 2026 in Review
IMC Chicago opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 55,491 shares worth $938K. The stake represents ﹤0.01% of the portfolio and ranks #4138 among its holdings. This is a return to the name: IMC Chicago previously reported a position in SMMT as recently as Q4 2025.
IMC Chicago first reported a position in SMMT in Q4 2025 and has held it in 2 quarters since. 298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- IMC Chicago held 55,491 shares of Summit Therapeutics worth $938K as of Q3 2026.
- Summit Therapeutics was a new IMC Chicago position in Q3 2026.
- Summit Therapeutics made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #4138 holding.
- IMC Chicago first reported a position in Summit Therapeutics in Q4 2025 and has held it in 2 quarters since.
- 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.